Literature DB >> 5602554

Fibrinolytic response of diabetics and non-diabetics to adrenaline.

A R Tanser.   

Abstract

The fibrinolytic response of 30 diabetic patients and 35 non-diabetics to 0.5 mg. subcutaneous adrenaline was measured, using the dilute clot lysis test. With the exception of two patients out of six who were taking phenformin, who had a depressed response, the diabetics showed a similar increase in fibrinolytic activity to the non-diabetics. The diabetics in this series did not tend to have longer spontaneous lysis times than the non-diabetics, although this type of comparison may not be valid.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5602554      PMCID: PMC473474          DOI: 10.1136/jcp.20.3.231

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

1.  FIBRINOLYTIC ACTIVITY IN DIABETES MELLITUS.

Authors:  N MACKAY; R HUME
Journal:  Scott Med J       Date:  1964-09       Impact factor: 0.729

2.  OBSERVATIONS ON ADRENALINE-INDUCED FIBRINOLYSIS IN MAN.

Authors:  A R TANSER; H SMELLIE
Journal:  Clin Sci       Date:  1964-06       Impact factor: 6.124

3.  THE PHARMACOLOGICAL ENHANCEMENT OF BLOOD FIBRINOLYTIC ACTIVITY WITH SPECIAL REFERENCE TO PHENFORMIN.

Authors:  G R FEARNLEY; R CHAKRABARTI
Journal:  Acta Cardiol       Date:  1964       Impact factor: 1.718

4.  Clearing factor, fibrinolysis and blood lipids in diabetes mellitus.

Authors:  M A DENBOROUGH; B PATERSON
Journal:  Clin Sci       Date:  1962-12       Impact factor: 6.124

5.  Reduction of blood fibrinolytic activity in diabetes mellitus by insulin.

Authors:  G R FEARNLEY; C T VINCENT; R CHAKRABARTI
Journal:  Lancet       Date:  1959-12-12       Impact factor: 79.321

  5 in total
  2 in total

1.  Fibrinolytic response to moderate exercise in young male diabetics and non-diabetics.

Authors:  J D Cash; R C McGill
Journal:  J Clin Pathol       Date:  1969-01       Impact factor: 3.411

2.  Abnormal endothelial release of fibrinolytic activity and fibronectin in diabetic microangiopathy.

Authors:  B Haitas; A J Barnes; S A Cederholm-Williams; J Moore; M E Shogry; R C Turner
Journal:  Diabetologia       Date:  1984-11       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.